
Dasa cuts net loss by 80% to R$35 million, generates R$292 million in free cash flow
EBITDA rises 53% on a comparable basis as margins improve and expenses decline; adjusted net debt…
Dasa (Diagnósticos da América) runs diagnostic laboratories, hospitals and oncology services.
DASA3 is the ticker of Dasa’s common shares (ON) on B3, listed in the Novo Mercado, the segment with B3’s strictest corporate-governance rules.
Company facts: CVM open data (Formulário Cadastral 2026), available under the ODbL. Descriptions by Brazil Stock Guide.

EBITDA rises 53% on a comparable basis as margins improve and expenses decline; adjusted net debt…

A BTG Pactual survey shows ten listed healthcare companies increased their combined workforce from about 166,000…

A minority stake sale could raise about R$10 billion and set the Brazilian health-plan operator on…
E-commerce giant takes first step into over-the-counter medicine sales, pending antitrust approval

New offering will provide access to Einstein, Sírio-Libanês and HCor, signaling a shift from the insurer’s…

Higher yields are drawing investors back to Brazil’s tax-free fixed-income market, but the surge also reveals…
Slate combines executives from the state-controlled oil company, the fund, a former BNDES chief, turnaround specialists…

Expansion of prepaid and low-cost healthcare services prompts push for greater transparency and clearer boundaries with…

Deal returns control of hospital and clinic in Botafogo to Amil from joint venture with Dasa.
DASA3 is the ticker of Dasa’s common shares (ON) on B3, the São Paulo stock exchange, where the company is listed in the Novo Mercado, the segment with B3’s strictest corporate-governance rules.
Yes. Non-resident investors can buy shares listed on B3 through a Brazilian custodian after registering with the CVM, the Brazilian securities regulator.
The quote, chart, technical rating, company profile and financials on this page are TradingView widgets with B3 market data. The company facts come from the CVM public register, and the news from the Brazil Stock Guide newsroom.
Market data by TradingView. Informational only — not investment advice.